|
Issue |
Title |
|
Vol 23, No 8 (2024) |
Enhanced external counterpulsation in the management of patients with ischemic heart failure: long-term impact on clinical outcomes |
Abstract
PDF (Rus)
|
A. S. Lishuta, E. V. Privalova, Yu. N. Belenkov |
|
Vol 23, No 8 (2024) |
Pulmonary hypertension in ischemic heart failure: a pilot study |
Abstract
PDF (Rus)
|
V. A. Mareyeva, A. A. Bogdanova, Т. A. Nikiforova, A. A. Klimenko |
|
Vol 23, No 7 (2024) |
Effectiveness of a virtual reality relaxation to correct symptoms of depression, anxiety, emotional and cognitive disorders in patients with heart failure |
Abstract
PDF (Rus)
|
Yu. F. Osmolovskaya, A. A. Petrukhina, Yu. O. Aksenova, I. V. Zhirov, A. G. Beniashvili, M. A. Morozova, S. N. Tereshchenko |
|
Vol 22, No 10 (2023) |
Markers of heart failure with preserved ejection fraction in patients with unexplained dyspnea |
Abstract
PDF (Rus)
|
A. A. Ivanova, E. A. Rogozhkina, Yu. S. Timofeev, O. N. Dzhioeva, O. M. Drapkina |
|
Vol 22, No 8 (2023) |
Bone mineral density and parameters of bone metabolism in men with heart failure of various origins |
Abstract
PDF (Rus)
|
E. K. Yaralieva, I. A. Skripnikova, R. P. Myasnikov, O. V. Kulikova, V. E. Novikov, M. A. Myagkova, V. A. Vygodin, O. M. Drapkina |
|
Vol 21, No 12 (2022) |
Detection rate and characteristics of heart failure, depending on the diagnostic criteria in COVID-19 survivors one year after hospitalization |
Abstract
PDF (Rus)
|
Yu. V. Mareev, M. M. Lukyanov, S. Yu. Martsevich, A. A. Pulin, N. P. Kutishenko, E. Yu. Andreenko, V. P. Voronina, V. A. Dindikova, N. A. Dmitrieva, A. N. Makoveeva, O. V. Lerman, E. Yu. Okshina, A. A. Smirnov, M. M. Kudryavtseva, E. N. Belova, V. G. Klyashtorny, E. V. Kudryashov, O. E. Karpov, O. M. Drapkina |
|
Vol 22, No 1 (2023) |
Characteristics of anemia in heart failure: iron metabolism, erythropoietic activity and markers of inflammation |
Abstract
PDF (Rus)
|
A. A. Gurkina, N. I. Stuklov, N. D. Kisly, R. R. Gimadiev, M. S. Kovalchuk |
|
Vol 21, No 10 (2022) |
Effect of spironolactone therapy on the activity of the matrix metalloproteinase system in patients with heart failure after COVID-19 |
Abstract
PDF (Rus)
|
V. I. Podzolkov, A. I. Tarzimanova, A. E. Bragina, I. I. Shvedov, E. E. Bykova, А. A. Ivannikov, S. S. Khanakyan, A. M. Almyasheva |
|
Vol 21, No 9 (2022) |
The relationship between gut microbiota, chronic systemic inflammation, and endotoxemia in patients with heart failure with preserved ejection fraction |
Abstract
PDF (Rus)
|
A. N. Kaburova, O. M. Drapkina, S. M. Yudin, A. A. Yafarova, S. N. Koretsky, M. S. Pokrovskaya, V. V. Makarov, S. A. Kraevoy, B. B. Shoibonov, I. A. Efimova, Z. Z. Serebryanskaya |
|
Vol 21, No 9 (2022) |
Echocardiographic characteristics of patients with ischemic and non-ischemic chronic heart failure with reduced ejection fraction |
Abstract
PDF (Rus)
|
N. N. Ilov, D. R. Stompel, S. A. Boytsov, E. I. Romantsov, A. A. Nechepurenko |
|
Vol 21, No 6 (2022) |
Results of pilot remote monitoring of heart failure patients |
Abstract
PDF (Rus)
|
N. V. Pyrikova, N. A. Mozgunov, I. V. Osipova |
|
Vol 21, No 3 (2022) |
Levels of angiogenesis markers in patients with different heart failure phenotypes |
Abstract
PDF (Rus)
|
R. N. Shepel, O. M. Drapkina |
|
Vol 21, No 2 (2022) |
Reverse remodeling against the background of cardiac contractility modulation therapy in patients with heart failure and atrial fibrillation |
Abstract
PDF (Rus)
|
A. A. Safiullina, T. M. Uskach, S. V. Dobrovolskaya, M. A. Saidova, M. I. Makeev, S. N. Tereshchenko |
|
Vol 19, No 5 (2020) |
Effect of therapy on the dynamics of collagen metabolism markers in older patients with heart failure with mid-range ejection fraction and coronary artery disease |
Abstract
PDF (Rus)
|
O. A. Osipova, E. V. Gosteva, Zh. Yu. Chefranova, N. I. Zhernakova, Yu. A. Lykov, I. V. Avdeeva |
|
Vol 19, No 6 (2020) |
Effects of spironolactone and eplerenone on left ventricular diastolic function and neurohumoral factors in patients with heart failure |
Abstract
PDF (Rus)
|
N. A. Nuritdinov, U. K. Kamilova |
|
Vol 19, No 3 (2020) |
Hepcidin and MELD-XI score as markers of multiple organ failure in patients with heart failure with preserved and reduced ejection fraction |
Abstract
PDF (Rus)
|
V. I. Podzolkov, N. A. Dragomiretskaya, S. K. Stolbova, A. V. Tolmacheva |
|
Vol 18, No 3 (2019) |
Prognostic algorithms for the progression of chronic heart failure depending on the clinical phenotype |
Abstract
PDF (Rus)
|
E. A. Polunina, L. P. Voronina, E. A. Popov, I. S. Belyakova, O. S. Polunina, D. S. Tarasochkina |
|
Vol 18, No 3 (2019) |
Features of cardiovascular remodeling, the level of neurohumoral factors depending on the degree of chronic heart failure and kidney dysfunction |
Abstract
PDF (Rus)
|
U. K. Kamilova, Z. D. Rasulova, G. A. Zakirova, B. B. Toshev |
|
Vol 18, No 2 (2019) |
Identification of latent disorders of carbohydrate metabolism in conjunction with neurohormonal status in hospitalized patients with chronic heart failure of ischemic etiology |
Abstract
PDF (Rus)
|
A. M. Noruzbaeva, B. T. Kurmanbekova, G. E. Osmankulova |
|
Vol 17, No 5 (2018) |
Prediction role of a novel biomarker ST2 in risk assessment of adverse cardiovascular events in chronic heart failure with preserved and intermediate ejection fraction after myocardial revascularization |
Abstract
PDF (Rus)
|
E. V. Grakova, A. T. Teplyakov, K. V. Kopieva, Sh. D. Akhmedov, O. N. Ogurkova, M. V. Soldatenko |
|
Vol 17, No 5 (2018) |
Analysis of inflammatory marker levels in patients with chronic heart failure |
Abstract
PDF (Rus)
|
E. A. Popov, E. A. Polunina, L. P. Voronina, O. S. Polunina, I. S. Belyakova |
|
Vol 17, No 5 (2018) |
Analysis of levels of oxidative stress markers depending on the left ventricular ejection fraction in patients with chronic heart failure |
Abstract
PDF (Rus)
|
E. A. Polunina, L. P. Voronina, E. A. Popov, O. S. Polunina |
|
Vol 17, No 1 (2018) |
PROGNOSTIC SIGNIFICANCE OF THE VNTR POLYMORPHISM INTRON 4 OF THE GENE OF NITRIC OXIDE ENDOTHELIAL SYNTHASE IN CHRONIC HEART FAILURE PATIENTS |
Abstract
PDF (Rus)
|
E. A. Polunina, Yu. G. Shvarts, I. V. Sevostianova, О. S. Polunina, L. P. Voronina |
|
Vol 16, No 6 (2017) |
INFLUENCE OF COMORBIDITIES ON BLOOD ALDOSTERONE LEVEL IN CHRONIC HEART FAILURE WITH PRESERVED SYSTOLIC FUNCTION OF THE LEFT VENTRICLE |
Abstract
PDF (Rus)
|
N. T. Vatutin, A. N. Shevelyok |
|
Vol 16, No 6 (2017) |
GENDER DIFFERENCE AND COMORBIDITIES IN CHRONIC HEART FAILURE PATIENTS |
Abstract
PDF (Rus)
|
R. T. Shukurov, T. A. Abdullaev |
|
Vol 16, No 6 (2017) |
PROGNOSTIC SIGNIFICANCE OF GALECTIN-3 LEVEL ASSESSMENT IN METABOLIC SYNDROME PATIENTS WITH HEART FAILURE |
Abstract
PDF (Rus)
|
O. M. Drapkina, R. N. Shepel, T. A. Deeva |
|
Vol 15, No 6 (2016) |
SELECTION OF THE OPTIMAL ANTIHYPERTENSION TREATMENT IN PATIENTS WITH CHRONIC HEART FAILURE WITH THE SIGNS OF CHRONIC KIDNEY DISEASE |
Abstract
PDF (Rus)
|
N. Yu Borovkova, Т. Е. Kuznetsova, N. N. Borovkov, A. A. Tulichev, A. S. Ilyina |
|
Vol 15, No 4 (2016) |
EVALUATION OF THE ROLE OF HYPERHOMOCYSTEINEMIA AND POLYMORPHISM C677T GENE OF METHYLTETRAHYDROFOLATEREDUCTASE IN DEVELOPMENT OF CHRONIC HEART FAILURE |
Abstract
PDF (Rus)
|
A. T. Teplyakov, E. N. Berezikova, S. N. Shilov, E. V. Grakova, Yu. Yu. Torim, A. V. Efremov, А. А. Popova, М. G. Pustosvetova, А. Yu. Sabirova, К. V. Kopieva |
|
Vol 15, No 2 (2016) |
Endothelium protecting properties of taurin in chronic heart failure with type 2 diabetes |
Abstract
PDF (Rus)
|
M. E. Stacenko, S. V. Turkina, N. N. Shilina, A. A. Vinnikova |
|
Vol 15, No 2 (2016) |
Gender and age specifics of clinical status, structure-functional parameters of the heart, and their relationship with psychoemotional state of patients with chronic heart failure after myocardial infarction |
Abstract
PDF (Rus)
|
G. M. Dadashova |
|
Vol 15, No 1 (2016) |
Prevalence and echocardiographic predictors of atrial fibrillation in patients with heart failure with preserved ejection fraction |
Abstract
PDF (Rus)
|
K. G. Adamyan, L. G. Tunyan, A. L. Chilingaryan, L. R. Tumasyan |
|
Vol 15, No 1 (2016) |
The involvement of kidneys in chronic heart failure patients with liver steatosis |
Abstract
PDF (Rus)
|
O. M. Drapkina, E. V. Zyatenkov |
|
Vol 15, No 1 (2016) |
Relation of the heart remodeling and endothelial dysfunction in chronic heart failure patients |
Abstract
PDF (Rus)
|
Ch. A. Abdullaeva, U. K. Kamilova |
|
Vol 14, No 6 (2015) |
ASSESSMENT OF THE N-TERMINAL COLLAGEN III-TYPE PROPEPTIDE IN PATIENTS WITH CHRONIC HEART FAILURE AND METABOLIC SYNDROME |
Abstract
PDF (Rus)
|
O. M. Drapkina, E. V. Zyatenkova |
|
Vol 14, No 4 (2015) |
NEW OPPORTUNITIES IN TREATMENT OF CHRONIC HEART FAILURE WITH NORMAL EJECTION FRACTION |
Abstract
PDF (Rus)
|
A. G. Dushina, R. A. Libis |
|
Vol 14, No 2 (2015) |
COMPARISON OF LOSARTAN AND LISINOPRIL EFFECTIVENESS FOR GLOMERULAR AND TUBULAR MARKERS OF RENAL DYSFUNCTION IN CHRONIC HEART FAILURE |
Abstract
PDF (Rus)
|
U. K. Kamilova, Z. D. Rasulova |
|
Vol 14, No 1 (2015) |
THE ANALYSIS OF CLINICAL, FUNCTIONAL, LABORATORY AND GENETIC PARAMETERS VALUES ON THE CONDITION OF PATIENTS AFTER MYOCARDIAL INFARCTION, AND PROGNOSIS OF INTRAMYOCARDIAL AUTOLOGIC CELL THERAPY EFFECTIVENESS FOR CHRONIC HEART FAILURE |
Abstract
PDF (Rus)
|
V. I. Konenkov, O. V. Poveshchenko, V. F. Prokofiev, A. V. Shevchenko, I. N. Kim, N. A. Bondarenko, A. M. Karaskov, E. V. Pokushalov, A. B. Romanov |
|
Vol 14, No 1 (2015) |
GENE POLYMORPHISM IN ASSOCIATION WITH ATHEROSCLEROSIS DEVELOPMENT AND COGNITION DISORDERS IN PATIENTS WITH ISCHEMIC CHRONIC HEART FAILURE |
Abstract
PDF (Rus)
|
T. V. Martynovich, N. S. Akimova, E. A. Fedotov, Yu. G. Shvarts |
|
Vol 13, No 4 (2014) |
INTERRELATION OF ATHEROSCLEROSIS RISK FACTORS AND CENTRAL NERVOUS SYSTEM CONDITION IN PATIENTS WITH CHRONIC HEART FAILURE OF ISCHEMIC ORIGIN |
Abstract
PDF (Rus)
|
N. S. Akimova, T. V. Martynovich, D. G. Persashvili, Yu. G. Shvarts |
|
Vol 13, No 4 (2014) |
CHANGES IN CLINICAL MANIFESTATION OF CONGESTIVE HEART FAILURE AT THE BACKGROUND OF REGULAR RAMIPRIL INTAKE |
Abstract
PDF (Rus)
|
A. G. Kuzmin, V. V. Gorbunov, O. V. Kuzmina |
|
Vol 13, No 2 (2014) |
THE EFFECTIVENESS OF CARVEDILOL AND EPROSARTAN IN PATIENTS WITH METABOLIC SYNDROME AND CHRONIC HEART FAILURE |
Abstract
PDF (Rus)
|
R. L. Dashnamirov |
|
Vol 13, No 2 (2014) |
KIDNEY DYSFUNCTION EVALUATION IN CHRONIC HEART FAILURE PATIENTS |
Abstract
PDF (Rus)
|
U. K. Kamilova, I. T. Alikulov |
|
Vol 11, No 6 (2012) |
Comparative effects of renin-angiotensin-aldosterone system modulators on right heart function and prognosis in patients with severe systolic chronic heart failure |
Abstract
PDF (Rus)
|
K. G. Adamyan, L. R. Tumasyan, A. L. Chilingaryan |
|
Vol 11, No 2 (2012) |
Differential approach in selecting beta-adrenoblocker therapy for patients with chronic heart failure and anaemia |
Abstract
PDF (Rus)
|
T. M. Uskach, A. G. Kochetov, S. N. Tereschenko |
|
Vol 10, No 2 (2011) |
Ivabradine therapy effectiveness in patients with chronic heart failure, Functional Class III |
Abstract
PDF (Rus)
|
S. G. Kanorskiy, V. G. Tregubov, V. M. Pokrovskiy |
|
Vol 10, No 2 (2011) |
Clinico-demographic characteristics of the patients with decompensated chronic heart failure Clinico-demographic characteristics of the patients with decompensated chronic heart failure |
Abstract
PDF (Rus)
|
S. N. Tereshchenko, I. V. Kositsyna, N. A. Dzhaiani, N. A. Gnidkina, A. V. Golubev |
|
Vol 10, No 1 (2011) |
Heart rate-reducing agents ivabradine and beta-adrenoblockers in the management of patients with stable effort angina |
Abstract
PDF (Rus)
|
Z. M. Galeeva, N. A. Andreichev |
|
Vol 10, No 1 (2011) |
Nebivolol effects on myocardial remodelling, inflammation markers and endothelial dysfunction in chronic heart failure patients with or without Type 2 diabetes mellitus |
Abstract
PDF (Rus)
|
Yu. N. Belenkov, E. V. Privalova, I. S. Chekneva, L. V. Knyazeva, N. S. Suleymanova, I. V. Vasilyeva |
|
Vol 9, No 2 (2010) |
Indapamide retard in complex therapy of patients with chronic heart failure and arterial hypertension |
Abstract
PDF (Rus)
|
S. N. Tereshchenko, N. A. Dzhaiani, A. E. Akimov, N. A. Gnidkina, A. G. Kochetov |
|
Vol 8, No 6 (2009) |
Atorvastain effectiveness in patients with heart failure, preserved systolic function, and paroxysmal atrial fibrillation |
Abstract
PDF (Rus)
|
E. S. Kozlova, A. S. Popova, Yu. M. Lopatin |
|
Vol 8, No 5 (2009) |
Cerebral circulation in hypertensive encephalopathy and chronic heart failure |
Abstract
PDF (Rus)
|
L. A. Geraskina, T. N. Sharypova, V. V. Mashin, V. Vl. Mashin, A. V. Fonyakin, Z. A. Suslina |
|
Vol 8, No 5 (2009) |
Metabolic disturbances and endothelial function in elderly patients with systolic and diastolic chronic heart failure |
Abstract
PDF (Rus)
|
I. A. Sukmanova, D. A. Yakhontov, I. V. Osipova |
|
Vol 8, No 5 (2009) |
Differential beta-adrenoblocker therapy in chronic heart failure: the role of age, gender, and co-morbidity |
Abstract
PDF (Rus)
|
S. N. Tereshchenko, I. V. Zhirov, A. V. Akinina, A. G. Kochetov |
|
Vol 8, No 3 (2009) |
Effects of moexipril and estrogen-progesterone combination in women with heart failure and menopausal syndrome |
Abstract
PDF (Rus)
|
Ya. I. Kots, O. D. Konstantinova, Yu. V. Liskova |
|
Vol 8, No 1 (2009) |
Diuretic therapy choice in the treatment of arterial hypertension and heart failure |
Abstract
PDF (Rus)
|
M. P. Savenkov, A. V. Kirichenko, S. N. Ivanov, M. V. Borshchevskaya, I. N. Okuneva |
|
Vol 7, No 7 (2008) |
Thrombotic event prevention in patients with post-infarction chronic heart failure, as а part of complex therapy including various classes of beta -adrenoblockers |
Abstract
PDF (Rus)
|
Yu. V. Larina, L. A. Nekrutenko, A. V. Tuev, A. V. Agafonov, I. P. Rubesh |
|
Vol 7, No 8 (2008) |
Beta-adrenoЬlockers in patients with chronic heart failure and chronic obstructive pulmonary disease |
Abstract
PDF (Rus)
|
M. E. Statsenko, D. A. Ivanova, O. E. Sporova, S. V. Belenkova |
|
Vol 7, No 5 (2008) |
Simvastatin therapy in elderly patients with chronic heart failure: potential cardiodepressive effects |
Abstract
PDF (Rus)
|
A. L. Pirogov, T. I. Vlasova |
|
Vol 7, No 5 (2008) |
Influence of endothelial NO synthase gene polymorphisms on development and prognosis of chronic heart failure |
Abstract
PDF (Rus)
|
N. F. Yakovleva, S. D. Mayanskaya, A. V. Yakovlev, M. L. Filipenko, E. N. Voronina, E. N. Berezikova, S. N. Shilov, T. I. Zakharova |
|
Vol 7, No 1 (2008) |
Long-term carvedilol therapy effects on left ventricular remodeling and glycemia in patients with chronic heart failure and Type 2 diabetes mellitus |
Abstract
PDF (Rus)
|
R. R. Samedov, A. B. Bakhshaliev |
|
Vol 7, No 1 (2008) |
Chronic heart failure risk factors in patients with chronic kidney pathology |
Abstract
PDF (Rus)
|
O. E. Ilyicheva |
|
Vol 7, No 1 (2008) |
Carvedilol therapy effects on structural and electric remodeling in chronic heart failure |
Abstract
PDF (Rus)
|
E. V. Minakov, R. A. Khokhlov, T. N. Kusnetsova, Yu. V. Popovskaya, E. E. Tsareva |
|
Vol 6, No 6 (2007) |
Depressive disorders in elderly patients with heart failure disease |
Abstract
PDF (Rus)
|
I. V. Osipova, N. V. Pogosova, Y. V. Sokolova |
|
Vol 6, No 1 (2007) |
Rational pharmacotherapy of chronic heart failure with increased endothelin-1 activity: beta-adrenoblocker nebivolol place |
Abstract
PDF (Rus)
|
L. I. Olbinskaya, Yu. I. Naymann |
|
Vol 6, No 1 (2007) |
Reversibility of chronic heart failure symptoms in chronic kidney disease patients |
Abstract
PDF (Rus)
|
V. V. Belov, O. E. Ilyicheva |
|
Vol 5, No 4 (2006) |
Fosinopril – a drug of choice in chronic heart failure prevention and treatment |
Abstract
PDF (Rus)
|
N. Yu. Khosyainova, V. M. Tsareva, O. V. Sukharukova, I. V. Milyagina |
|
Vol 5, No 4 (2006) |
Prognostic value of high-resolution electrocardiography parameters, heart rate variability, and QT interval dynamics in patients with chronic heart failure |
Abstract
PDF (Rus)
|
A. E. Radzevich, V. V. Popov, N. A. Bulanova, M. Yu. Knyazeva |
|
Vol 4, No 5 (2005) |
Trimetazidine effects on heart and kidney functional status, and quality of life in long-term complex treatment of chronic heart failure in elderly patients |
Abstract
PDF (Rus)
|
M. E. Statsenko, O. E. Sporova |
|
1 - 68 of 68 Items |
|